PA
IP

Invictus Pharmacy

Nationwide pharmacy delivering affordable DTC meds via direct manufacturer partnerships, tech platform, and superior retention.

Visit Website

Known For

Bypasses PBMs/wholesalers for 56% lower prices

Key Differentiators

  • Bypasses PBMs/wholesalers for 56% lower prices
  • 85% refill rate vs 60-70% industry avg
  • nationwide licensure with proprietary tech platform

Overview

Vertically integrated nationwide pharmacy platform offering direct-to-consumer prescription dispensing via retail, mail-order, and digital channels. Partners directly with drug manufacturers to bypass PBMs and wholesalers, providing transparent DTC pricing and high patient retention (85% refill rate). Operates 50-state licensed mail-order pharmacy with proprietary e-commerce and claims adjudication technology, serving over 1M patients.

Services & Capabilities

  • Mail-order and retail prescription dispensing (brand/generic), nationwide free delivery, prior authorization support, custom compounding, pet medications, OTC products, crypto payments, proprietary e-commerce platform, claims adjudication technology, direct manufacturer partnerships for DTC pricing.

Competitive Position

  • Bypasses PBMs/wholesalers for 56% lower prices
  • 85% refill rate vs 60-70% industry avg
  • nationwide licensure with proprietary tech platform

Recent Developments

Jan 2026: Strategic acquisition of additional pharmacy operations to expand national DTC platform (PR Newswire). Sept 2025: Secured licensure in all 50 states + territories (PR Newswire). Nov 2025: First to accept crypto (ETH, SOL, XRP) for prescriptions (CNW). No mentions in FiercePharma, Drug Channels, etc.

Client & Partner Ecosystem

Drug manufacturers (unnamed); served 1M+ patients

Technology Platform

Proprietary e-commerce and claims adjudication platform; blockchain-based payments (developing)

Therapeutic Focus

broad/all

Target Customers

Patients (individuals, employer groups), pharmaceutical manufacturers (for DTC sales and retention)

Sources